『The Energy Code』のカバーアート

The Energy Code

The Energy Code

著者： Dr. Mike Belkowski
無料で聴く

The Energy Code is your blueprint for unlocking limitless vitality at the cellular level. Hosted by Dr. Mike Belkowski, this podcast dives deep into the science of your mitochondria—the true engines of health and energy. From light, water, and magnetism to groundbreaking molecules and lifestyle upgrades, each episode decodes the most effective strategies to strengthen your “Mitochondrial Matrix.” If you’re seeking cutting-edge science, practical tools, and proven methods to optimize your body and mind, you’ve just cracked the code. Check out these sources: www.biolight.shop – Instagram @biolight.shop – YouTube BioLight

Copyright 2021 All rights reserved. 代替医療・補完医療 衛生・健康的な生活
エピソード
  • SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source

    SS-31: The Peptide ‘Mitochondrial Shield’ That May Block Parkinson’s Damage at the Source
    2026/06/05
    This is the first dedicated peptide deep dive of The Energy Code — and it starts with arguably the most mitochondrial-centric peptide on the board: SS-31 (Elamipretide). Dr. Mike breaks down a new paper showing how SS-31 may protect neurons in Parkinson’s disease by competing with alpha-synuclein at lipid membranes, slowing toxic aggregation, restoring mitochondrial respiration, and even reducing alpha-synuclein cellular entry. You’ll also hear a key caution: SS-31 appears highly protective at moderate doses, but too much may flip the benefit into harm, reinforcing the “dose makes the medicine” rule in mitochondrial pharmacology. (Educational content only, not medical advice.) - Article Discussed in Episode: Therapeutic Peptide SS-31 Modulates Membrane Binding and Aggregation of α-Synuclein and Restores Impaired Mitochondrial Function - Key Quotes From Dr. Mike: “The future of Parkinson’s therapy may not lie in cleaning up the mess, but rather in providing our neurons with a permanent molecular shield…” “SS-31 acts as a molecular shield protecting the brain’s energy supply…” “SS-31 acts as a molecular bouncer, physically evicting alpha-synuclein from lipid membranes…” “SS-31 substantially prolonged the lag phase of aggregation, essentially stalling the clock on protein buildup.” “These findings underscore the multifaceted protective role of SS-31 against mitochondrial dysfunction caused by alpha synuclein aggregation... SS-31 reversed this decline with a 10 micromolar dose…” - Key Points SS-31 is framed as a mitochondria-first peptide: “restore impaired mitochondrial function” is the headline.Parkinson’s pathology is presented as a cellular power failure inside dopaminergic neurons driven by alpha-synuclein toxicity.SS-31 may act like a “molecular bouncer” — outcompeting alpha-synuclein for anionic lipid membranes and preventing harmful binding/folding.The episode highlights the real-world complication: N-terminal acetylated alpha-synuclein (common in humans) embeds deeper and is harder to displace.SS-31 appears to delay aggregation kinetics (longer “lag phase”) and shift aggregate morphology toward potentially less toxic off-pathway forms.Mitochondrial function was assessed with a Seahorse mito stress test; SS-31 is described as restoring basal/max respiration (at a cited 10 μM dose).Mechanistically, SS-31 is explained as: Cardiolipin binding → supports OXPHOS efficiency/ATP outputROS scavenging (tyrosine residue) → reduces oxidative damage SS-31 may also reduce alpha-synuclein oligomer uptake by altering membrane electrostatics (less negative surface charge).A major warning: very high concentrations (described as >100 μM) may trigger apoptosis / reduce viability.Big-picture: SS-31 supports a “prevention-first” strategy — block the lipid–protein interaction upstream, rather than “cleaning up the mess” later. - Episode timeline 0:00–0:40 — Why peptides are the next major content focus; why SS-31 is the first peptide deep dive0:40–3:55 — Paper intro + “SS-31 restores impaired mitochondrial function” framing; what the show will cover and why it matters3:55–5:44 — Parkinson’s as mitochondrial “power failure”; alpha-synuclein as the driver; SS-31 as a BBB-permeable candidate5:44–6:58 — Takeaway #1: SS-31 as a “molecular bouncer” displacing alpha-synuclein from membranes (dose-dependent)6:58–8:16 — Takeaway #2: N-terminal acetylation makes alpha-synuclein “stickier” and harder to displace (real-human relevance)8:16–9:40 — Takeaway #3: Aggregation kinetics + morphology shifts (stalling the “snowball”)9:40–11:40 — Takeaway #4–#5: Respiration rescue + membrane/cell-entry effects; the dual mechanism (cardiolipin + ROS)11:40–13:20 — Dose caution, wrap-up, and the “designer peptides” future-forward conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
    続きを読む 一部表示
    15 分
  • The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1

    The Energy Code Blueprint: Longevity Starts in the Mitochondria, Pt. 1
    2026/06/04
    In this special edition of The Energy Code, Dr. Mike shares a more in-depth discussion on his presentation from Dave Asprey’s BEYOND Biohacking event in Austin: The Energy Code Blueprint: Longevity Starts in the Mitochondria. He introduces BioLight Labs’ initial focus on mitochondrial and longevity peptides, then delivers a thorough foundation on bioenergetics — why “more energy per cell” translates to more vitality, how redox/voltage and electrons relate to inflammation, and why mitochondria act as environmental sensors that drive epigenetics. From there, the episode begins the 6 Pillars of Mitochondrial Wellness, covering Pillar 1 (Energy Production ) —including electron transport chain efficiency and EZ water — and Pillar 2 (Mitogenesis) —with key activators like exercise, fasting, cold exposure, PQQ, urolithin A, and red/near-infrared light. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: “The more energy you produce per cell, the more vitality you will have... The less energy you produce per cell, the closer to a state of disease you will be.”“Around 80% of modern diseases are directly tied to mitochondrial dysfunction.”“Any wellness strategy that involves harnessing electrons is inherently anti-aging.”“Epigenetics is rooted in the mitochondria. They sense your environment and then send signals to the cell nucelus, which then turns genes on/off based on those mitochondrial signals."“Cardiolipin… is like the bedrock of mitochondrial function... Many researchers now believe cardiolipin deterioration is one of the central hallmarks of mitochondrial aging.”“SS-31’s mission is to fix and repair and prevent damage to cardiolipin. This makes SS-31 the MOST IMPORTANT peptide for mitochondrial function and anti-aging, from the bioenergetic perspective."“After the age of 30, we typically lose about 1% of energy production annually.”“Mitochondrial decline drives the hallmarks of aging... The future is clearly bioenergetic.” - Key Points ⚡️ Longevity is downstream of bioenergetics: more energy produced per cell → more vitality; less energy → disease trajectory. ⚡️ Mitochondria are upstream of symptoms: dysfunction can precede diagnosis by years/decades. ⚡️ “Healing is Voltage”: redox potential, electron availability, pH, and inflammation are tightly linked. ⚡️ Mitochondria are not just power plants — they are environmental sensors (MIPS) driving epigenetic gene expression via retrograde signaling. ⚡️ Mitohormesis reframes “stress” as a dose-dependent upgrade signal for mitochondria (exercise, fasting, cold/heat, light, key compounds). ⚡️ Cardiolipin is presented as “the mitochondria of the mitochondria,” central to cristae structure, ETC organization, and mitochondrial aging. ⚡️ SS-31 is framed as a top-tier cardiolipin-targeting peptide; MOTS-c, Humanin, SHLP-2 as key mitochondrial-derived peptides. ⚡️ Energy production includes ATP + EZ water: ATP as immediate currency; EZ water as mitochondrial “battery pack” and hydration reserve. ⚡️ Red and near-infrared light are positioned as major tools to expand EZ water and support mitochondria across multiple pillars. ⚡️ The presentation tees up a “6 pillars” framework and promises a next episode continuation (pillars 3–6 + applications). - Episode timeline 00:00–01:55 — Special edition + Beyond Biohacking context; BioLite Labs intro (peptides focus) 01:55–04:52 — Talk format notes + offer to email slides as a resource 04:52–08:54 — Overview: bioenergetics → 6 pillars → optimization strategies → “day in the life” blueprint 08:55–11:02 — Bioenergetics foundation: “more energy per cell = more vitality” (Doug Wallace framing) 11:03–13:50 — Mitochondria as root cause: cells → tissues → organs → systems; symptoms appear late 13:51–17:32 — Voltage/redox: electrons, pH, inflammation; examples (sunlight, grounding, electron-rich strategies) 17:33–19:04 — “Anti-aging via electrons”: shared thread across many wellness strategies 19:07–21:21 — Mitochondria as environmental sensors (MIPS) + retrograde signaling → epigenetics 21:23–24:42 — Mitohormesis: what doesn’t kill mitochondria makes them stronger; key stressors/benefits 24:45–31:56 — Cardiolipin deep dive: cristae structure, fragility to oxidative stress, downstream consequences; SS-31 spotlight 31:57–35:55 — Mitochondrial lens of aging: “energy cliff” concept; mitochondrial decline drives aging hallmarks 36:39–38:00 — “Future is bioenergetic”: move from managing decline to engineering resilience 38:01–40:10 — Six pillars introduced: energy, biogenesis, mitophagy, dynamics, ROS protection, light 40:11–46:22 — Pillar 1 (part 1): ETC mechanics; complex I/III issues; methylene blue + taurine note 46:23–51:25 — Pillar 1 (part 2): EZ ...
    続きを読む 一部表示
    1 時間 2 分
  • Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse

    Mitoredox: The “Electron Flow” Master Switch Behind Aging, Disease, and Mitochondrial Collapse
    2026/06/03
    This Deep Dive breaks down a preprint review from Free Radical Biology & Medicine titled “Mitoredox Shifts in Mitochondrial Dysfunction.” Dr. Mike opens with a TL;DR and then goes deeper into the core idea: a “mitoredox shift” (a disruption in mitochondrial redox balance) may be the unifying axis linking oxidative stress to mitochondrial quality-control failure, genome instability, heteroplasmy drift, and regulated cell death. The episode draws a clean line between primary genetic mitochondrial syndromes and far more common secondary mitochondrial dysfunction driven by environmental/metabolic stressors, then explores five big concepts: why redox imbalance collapses mitophagy and mtDNA stability, how “healthy” mitochondria can become hyperactive and accelerate disease, the 60–80% heteroplasmy tipping point, the reperfusion paradox, and emerging frontiers like mitochondrial transplantation, AI-driven oculomics, and new redox-modulating drugs — plus Dr. Mike’s “mitochondrial triad” lens (red light, methylene blue, C60). (Educational content only, not medical advice.) - Article Discussed in Episode: Mitoredox shifts in mitochondrial dysfunction - Key Quotes From Dr. Mike: “Mito-redox shifts… serve as a central link between oxidative stress and various diseases.” “These shifts destabilize essential cellular processes such as mitophagy and mitochondrial DNA stability…” “We are entering an era of mito redox medicine where we manage the electron flow of life itself.” “The retina is the only part of the central nervous system that can be imaged non-invasively… Whereby fluorescence imaging can detect metabolic failures years before physical symptoms appear… that is game changing.” “Life is defined by the steady controlled flow of electrons… when that flow is disrupted… our mitoredox shifts towards mitochondrial dysfunction and, ultimately, disease." - Key Points The review frames mitoredox shifts as a central link between oxidative stress and diverse diseases.Distinguishes primary mitochondrial syndromes (genetic) vs secondary disorders (environmental/metabolic)—with secondary being far more common.Mitoredox shifts destabilize mitophagy + mtDNA stability, leading to dysfunctional organelle buildup and cell death.The shift acts like an upstream master switch, biasing cells toward regulated death programs (e.g., ferroptosis, cuproptosis).“Healthy mitochondria can be hyperactive”: compensatory overwork can spike ROS and accelerate heteroplasmic drift.Heteroplasmy threshold: symptoms often emerge when mutated mtDNA crosses ~60–80%.Proposed takeover mechanisms: faster replication of truncated genomes, mitophagy decline, “survival of the sickest” evasion, random drift.Reperfusion paradox: restoring oxygen after ischemia can trigger a ROS surge that worsens injury and inflammation.Diagnostics: biomarkers + retinal imaging/oculomics, with AI methods potentially detecting dysfunction yearsearly.Therapeutics: mitochondrial transplantation, novel redox modulators (e.g., PMX 500FI), and “electron-flow stabilization” strategies. - Episode timeline 0:00–0:20 — Intro + review title + journal + preprint context (publishing Sept 2026)0:20–1:22 — New format: TL;DR first, then deeper dive1:22–2:56 — TL;DR: mitoredox shifts as the bridge between oxidative stress and disease; primary vs secondary; diagnostics + therapies; goal = restore homeostasis3:00–5:01 — Mythology + endosymbiosis framing: “bioenergetic fire,” mitochondria as life/death controllers5:01–6:58 — Concept 1: Mitoredox shift as the “unified field theory” linking ROS/antioxidants, QC failure, genome instability, regulated cell death7:03–9:05 — Concept 2: “Healthy mitochondria” hyperactivity + metabolic asymmetry + heteroplasmic drift9:05–11:59 — Concept 3: 60–80% tipping point; takeover mechanisms; aerobic glycolysis as a “stealth” adaptation11:59–13:38 — Concept 4: reperfusion paradox; ROS overload → vascular destabilization + inflammation; eye/oculomics relevance13:41–18:26 — Concept 5: future interventions—mito transplantation, AI oculomics, redox drugs (PMX 500FI) + Mike’s redox “triad” (RLT/MB/C60)18:26–19:25 — Closing: mitochondria as redox arbiters; “electron flow of life” question + final thought - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight Labs: Website Instagram BioLight: Website Instagram YouTube Facebook
    続きを読む 一部表示
    21 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません